Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-21-003659
Filing Date
2021-03-31
Accepted
2021-03-31 17:26:07
Documents
83
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT azrx10k_dec312020.htm 10-K 2534898
2 EXHIBIT 4.19 ex4-19.htm EX-4 45184
3 CONSENTS OF EXPERTS AND COUNSEL ex23-1.htm EX-23 4196
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 18763
5 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 18959
6 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32 12324
  Complete submission text file 0001654954-21-003659.txt   6025057

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT azrx-20201231.xml EX-101.INS 790804
8 XBRL TAXONOMY EXTENSION SCHEMA azrx-20201231.xsd EX-101.SCH 51166
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20201231_cal.xml EX-101.CAL 55793
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20201231_def.xml EX-101.DEF 128810
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20201231_lab.xml EX-101.LAB 301094
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20201231_pre.xml EX-101.PRE 254689
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37853 | Film No.: 21794764
SIC: 2834 Pharmaceutical Preparations